The efficacy of 3-IAA and FOLFIRINOX is independent of AHR of immune and cancer cell origin, suggesting that 3-IAA-oxidized derivatives have anti-proliferative effects on cancer cells in a cell-intrinsic fashion. The gene discussed is AHR; the disease is cancer.